UNSPSC 51285201: Baquiloprim

This classification denotes an antiprotozoal agent with the molecular formula C17H20N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DE766VIG6, chemically known as 5-((2,4-diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline but more generally known as baquiloprim, which bears US NIH Compound Identifier 72121. European Medicines Agency schedules Baquiloprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06100MIG. The term BAQUILOPRIM is an International Non-Proprietary Name.

BAQUILOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51285201 Baquiloprim, a Commodity code, shows minimal direct alignment with recent state and local procurement activity, though the code's pharmaceutical product scope appears tangentially related to broader pharmaceutical and medical supply procurement across state and local health agencies. Recent opportunities tagged under this code predominantly involve naloxone, safe drug deactivation systems, generic pharmaceuticals, over-the-counter products, and emergency medical supplies rather than baquiloprim specifically. State and local issuing bodies soliciting under this code include county health departments (Seminole County, Florida), state health and human services commissions (Texas Health and Human Services Commission), municipal fire departments (City of Tampa Fire Department Rescue Division), and cooperative purchasing alliances spanning multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across Minnesota and Oregon). The work involves procuring pharmaceutical products, emergency medical supplies, and related items for direct use by health departments, emergency services, and state and local healthcare systems.

Geographically, recent activity centers in Florida, Texas, and Minnesota, with cooperative purchasing extending across Oregon. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and sheltered-market designation for certified Small Local Business Enterprises (SLBEs) including a 5 percent SLBE bid discount capped at $10,000; the Texas Health and Human Services Commission's RFI HHS0017013 soliciting vendor capabilities for direct-to-manufacturer prescription programs, posted April 3, 2026; and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026, requiring cGMP and Drug Supply Chain Security Act compliance and distribution through authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson.